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Chronic liver injury from diverse causes
such as viruses, parasites, alcohol, heredi-
tary metal overload, for example, Wilson
disease, and xenobiotics may give rise to a
constellation of abnormalities such as fatty
change, apoptosis, necrosis, cholestasis,
inﬂammation, and ﬁbrosis as well as nodu-
lar regeneration and cirrhosis. As a para-
digm for parenchymal wound healing in
other tissues, chronic liver injury involves
the activation of cytokines believed not
only to mediate inflammation, necrosis,
apoptosis, and fibrosis but also regenera-
tion of liver tissue (Tilg and Diehl 2000).
As with many diseases, progression reﬂects
a combination of genetic and environmen-
tal factors, and the severity of the inflam-
matory process usually correlates with the
rate of disease progression. In hereditary
conditions such as hemachromatosis, a
concurrent insult such as alcohol ingestion
will increase injury and rate of progression
to ﬁbrosis (Friedman 1993). Other compli-
cating factors include older age, immune
status, male gender, and obesity (Friedman
1993; Tilg and Diehl 2000). Drug-induced
liver injury also continues to be a signifi-
cant problem (Bissell et al. 2001) where
genetically determined differences in drug-
metabolizing enzymes in the generation of
toxic metabolites as well as in immune
responses may be important (Lee 1995).
However, the relative importance of these
genetic factors and the way they might
interact are not fully understood. One
approach to help understand these factors
and their interaction in the evolution of
liver injury is through the use of gene
expression proﬁles.
Griseofulvin is an antifungal agent
that, when administered chronically to
mice, produces a variety of hepatic
responses the chronology of which have
been extensively studied (Knasmuller et al.
1997). Early cell proliferation leads to an
increase in liver/body weight ratio, and
alteration of the liver drug-metabolizing
profile (Knasmuller et al. 1997). One of
the earliest features of griseofulvin expo-
sure is a hepatic porphyria characterized by
the accumulation of protoporphyrin IX
(De Matteis and Rimington 1963; Weston
Hurst and Paget 1963). This porphyria is
induced by the inhibition of ferrochelatase
probably caused by a griseofulvin adduct
of protoporphyrin IX produced in a
cytochrome P450 (Cyp)-mediated suicide
reaction (Bellingham et al. 1995). The
changes in liver pathology with griseoful-
vin are similar to those found with human
erythropoietic protoporphyria (EP)-associ-
ated liver failure that occurs in a subset of
patients and probably depends on genetic
and physiologic susceptibility factors to
determine its onset (Bloomer et al. 1998;
Cox et al. 1998; Kappas et al. 1995).
Previous studies have used transcriptome
data to categorize the toxicity of chemicals
according to their gene expression profile,
the premise being that those chemicals with
a different type and/or mechanism of toxic-
ity will produce different gene expression
patterns. This approach was used by Waring
et al. (2001) to distinguish 15 different
hepatotoxins, a study which illustrated the
utility of this approach. Similar studies have
been carried out on smaller compound sets
by Hamadeh et al. (2002a, 2002b).
Working on the hypothesis that it is neces-
sary using statistical analysis to determine
only a relatively small number of gene
expressions to differentiate toxicity proﬁles,
Thomas et al. (2001) used 12 transcripts to
differentiate a set of 12 hepatotoxins. This
approach is potentially reductionist, how-
ever, and although successful on 12 previ-
ously characterized hepatotoxins, there is no
guarantee that it works on novel agents
using such a small number of genes. None
of the above studies have addressed the
potential influence of cellular response,
altered organ homeostasis, and resulting
pathologic change on gene expression pro-
files. This issue was addressed later by
Hamadeh et al. (2002c), who were able to
associate gene expression profiles with
pathologic change in the liver after
methapyrilene exposure. By making a corre-
lation between gene expression proﬁles and
pathologic change, these authors were able
to demonstrate the ability of gene expression
profile data to inform and enhance rather
than replace the pathologic analysis. The
application of gene expression profiles in
toxicology and pathology has been recently
reviewed (Gant 2002).
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Erythropoietic protoporphyria patients can develop cholestasis, severe hepatic damage, ﬁbrosis, and
cirrhosis. We modeled this hepatic pathology in C57BL/6J and BALB/c mice using griseofulvin
and analyzed 3,127 genes for alteration of expression in the liver before and during the onset of
protoporphyria, cholestasis, inﬂammation, and hepatic ﬁbrosis. The two mouse strains developed
different levels of pathologic damage in response to the griseofulvin. Characteristic gene expression
proﬁles could be associated with griseofulvin-induced gene expression, disruption of lipid metabo-
lism, and the pathologic states of inﬂammation, early ﬁbrosis, and cholestasis. Additionally, some
genes individually indicated an alteration of homeostasis or pathologic state; for example, ﬁbroblast
proliferation was potentially indicated by increased calcyclin (SA100a6) expression. Changes in
cytochrome P450 (Cyp) gene expression were particularly pronounced, with increased expression
of the Cyp2a, Cyp2b, and Cyp3a families. Decreased Cyp4a10 and Cyp4a14 expression was
observed that could be associated with early pathologic change. A potential decrease in bile acid
and steroid biosynthesis was indicated by the decreased expression of Cyp7b1 and Hsd3b4, respec-
tively. DNA damage was indicated by induction of GADD45. This study illustrates how transcrip-
tional programs can be associated with different stimuli in the same experiment. The time course
of change in the gene expression proﬁle compared with changes in pathology and clinical chemistry
shows the potential of this approach for modeling causative, predictive, and adaptive changes in
gene expression during pathologic change. Key words: fibrosis, inflammation, liver, microarray,
protoporphyria. Environ Health Perspect 111:847–853 (2003). doi:10.1289/txg.5849 available via
http://dx.doi.org/ [Online 18 November 2002]
Toxicogenomics | ArticleIn this study, cDNA microarray analysis
was used to generate gene expression proﬁles
associated with the early development of
protoporphyria and the complex pattern of
liver pathology that developed. These gene
expression profiles then were used to pro-
duce a molecular map of pathologic change
and griseofulvin exposure in this system.
Materials and Methods
Griseofulvin treatment of mice. Male
BALB/c and C57BL/6J mice were obtained
from Harlan Olac (Bicester, UK) at 6
weeks of age and acclimatized for 1 week
on Rat and Mouse No. 1 maintenance
(RMI; Special Diet Services, Witham, UK)
ﬁne ground diet prior to use. Animals were
housed in negative pressure isolators at
approximately 21°C with a 12-hr light-
dark cycle. After acclimatization the diet
was changed to one of RMI F.G. (fine
ground) as above but containing either 2%
arachis oil alone (control mice) or 2%
arachis oil and 1% griseofulvin (w/w)
obtained from Sigma Ltd. (Poole, Dorset,
UK). Dose selection was based on prior
experience and published data (De Matteis
et al. 1966). Experiments were performed
in accordance with Home Office license
number 80/1329. Diet consumption was
assessed by weighing the hoppers before
reﬁlling with diet on a daily basis, and indi-
cated an approximately equal consumption
by all groups. Animals were weighed every
3 days and removed from the study if the
body weight fell below 80% of controls
(one BALB/c animal was removed from the
study on this basis). At the indicated times,
blood was removed by cardiac puncture
under halothane anesthesia before sacriﬁce
by cervical dislocation. The liver was
removed quickly for histology or stored in
liquid nitrogen for RNA extraction.
Histologic methods. Liver tissue was
ﬁxed in 10% neutral buffered formalin and
conventional histologic sections 5 µm thick
were prepared and stained with hema-
toxylin and eosin and Van Gieson’s stain
for collagen. The study pathologist assessed
the amount of hepatic pigment deposition
and the degree of portal tract inflamma-
tion/bile duct proliferation in all animals in
a blinded manner. A limited four-point
scale was used to assure consistency
(Shackelford et al. 2002). No lesion was
represented by 0, minimal = 1, moderate = 2,
and severe = 3. The scores were summated
for each group of four mice to provide an
overall estimate of the severity of these
changes at each time point.
Clinical chemistry. Protoporphyria was
assessed by estimation of the proto-
porphyrin content of the liver determined
by spectroﬂuorimetry using the method of
Grandchamp et al. (1980). Plasma aspar-
tate aminotransferase (AST), alanine
aminotransferase (ALT), and alkaline phos-
phatase (AP) were measured using kits
from Sigma, according to the manufac-
turer’s instructions.
Microarray analysis of gene expression.
Analysis of gene expression was carried out
using cDNA arrays containing 3127 EST
(expressed sequence tag) clones for unique
genes. There were quadruplicate sets of
mice (control and treated) at each time
point for each strain, and one array was
used for each pair of mice. Thus, there
were four sets of differential expression
data for each time point in each strain.
Microarray preparation, RNA labeling and
hybridization were carried out as previ-
ously described (Turton et al. 2001) using
ESTs derived from Research Genetics or
from the IMAGE collections held at the
MRC Human Gene Mapping Project
(http://www.hgmp.mrc.ac.uk). The average
length of the clones spotted on the array
was 1028 bp. Fluorescent data derived from
microarray features where either the poly-
merase chain reaction preparation of the
clone had failed or a single product band had
not been obtained were removed from the
data set prior to normalization and analysis.
The clone databases detailing the clones
used on these arrays can be accessed from
the MRC Toxicogenomics Unit website
(http://www.le.ac.uk/cmht/microarray_lab/
Home). The clones shown in the ﬁgures were
sequenced to conﬁrm identity. 
Data analysis. Data analysis was carried
out as previously described (Turton et al.
2001). Brieﬂy, a measure of the median ﬂu-
orescent intensity of the pixels within the
hybridized feature area on the microarray
for each gene was obtained using an Axon
4000A scanner (Axon Instruments, Inc.
Union City, CA, USA). The measure of
fluorescent feature intensity was accepted
for further analysis if greater than 1.2 times
the local background. The threshold above
background was determined empirically as
that required to avoid using measures of ﬂu-
orescence in the low intensity range where
variance between experimental replicates is
high. Normalization of the channels was
carried out using the median fluorescence
feature intensity for each channel, as previ-
ously described (Turton et al. 2001), which
was calculated after removal from the data
set of all features where there was no poly-
merase chain reaction (PCR) product or the
PCR product was not a single band on
agarose gel analysis. The change in each
gene expression was calculated by determin-
ing the fold change (ratio) of the normal-
ized ﬂuorescent intensities of each channel.
These ratios were expressed on a log2 scale
to normalize their distribution. Features
where there were fluorescent data in one
channel only were given an arbitrary log2
ratio value of 10 if the ﬂuorescent intensity
in the single channel was greater than 0.5
times the mean ﬂuorescence intensity of the
channel. For clustering purposes, changes in
gene expression were assigned a score value
on a scale or –1 to 1, depending on their
position within the log2 (ratio) distribution,
with those in the 95% confidence bands
getting scores closer to 1 as previously
described (Turton et al. 2001). Hierarchical
clustering was then carried out using these
score values. For the purposes of presenta-
tion, the log2 values were incorporated only
in the clusters if the mean ratio change
across the replicate experiments had a p
value of <0.05 when compared with the
population mean of the normalized data
using a two-tailed t-test. This resulted in
apparent anomalies in some time-course
data points in Figure 3 where significance
was not quite achieved due to high variance
in the data at these particular points. These
data points are shown as nondifferentially
expressed, apparently contradicting the
time-course trend. Software used in data
analysis: for analysis of feature area ﬂuores-
cent intensity, GenePix 3.0.0.85 or 3.0.5
(Axon Instruments); for data normaliza-
tion, conversion, and statistical analysis,
ConvertData 3.4.0c and Condenser 2.0.3
available from the MRC Toxicogenomics
Unit website; for clone mapping and gene
information updating, CloneMapper 1.0.4
(available on request from the correspond-
ing author); for clustering and visualiza-
tion, Cluster 3.0 and Treeview 1.5 (Eisen
et al. 1998; http://rana.lbl.gov). Access2000
(Microsoft, Seattle, WA, USA) served
the database requirements of this study.
Interpretation of the data in terms of
assigning function to the genes was
achieved using information from the
GeneCards (http://nciarray.nci.nih.gov/
cards), GeneOntology from Amigo
(http://www.godatabase.org) and GenomeNet
(http://www.genome.ad.jp) databases in
addition to literature searches.
Results
Histopathologic assessment of liver injury.
Microscopic examination showed the
pathologic change induced by griseofulvin
was more apparent in C57BL/6J mice than
in BALB/c mice (Figure 1). By day 1 only
very minor focal inflammation in the
C57BL/6J mice was seen, but more consis-
tent focal inﬂammation was present by day 3
(Figure 1H). This was accompanied by
deposition of red-brown pigment (proto-
porphyrin) from day 3 that was seen in the
majority of the mice by day 5 (Figure 1G).
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tocytes, bile ducts, and occasional Kupffer
cells increased throughout the time course
of the experiment but was usually greater in
the C57BL/6J mice. Portal tract inﬂamma-
tion started to appear by day 5 consistently
in the C57BL/6J mice in contrast to the
BALB/c mice, where only one instance of a
minor focal lesion was observed at this time
point. The severity of inflammation and
bile duct proliferation increased in the
C57BL/6J mice throughout the time course
of the study but again remained less marked
in the BALB/c mice (Figure 1A–F). Focal
parenchymal necrosis was also a feature of
the treated C57BL/6J mice by days 5, 8,
and 15 but was only seen to a minor extent
in the BALB/c mice by day 22. Specific
staining showed early ﬁbrosis by day 15 in
the livers of the C57BL/6J (Figure 1C) but
not BALB/c mice (Figure 1D); ﬁbrosis was
more extensive in both strains by day 22
(Figure 1E, F).
Analysis of the livers indicated a highly
significant (p < 0.01) increase in the
amount of protoporphyrin in the livers of
the griseofulvin-treated mice closely reﬂect-
ing the histologic assessment of the proto-
porphyria (Figure 2B). Both strains of
mouse showed a significant elevation of
Toxicogenomics | Gene expression proﬁling of the cholestatic liver
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Figure 1. (A, B). Low-power views of the liver from 15-day griseofulvin-treated mice: C57BL/6J (A) and BALB/c (B). (C, D) Higher-power views of livers from 15-day
griseofulvin-treated mice: C57BL/6J (C) and BALB/c (D). (E, F) Same as for C and D except they are taken from 22-day griseofulvin-treated mice. (C–F) Counterstained
with Van Gieson’s stain for collagen deposition. (G) Histologic assessment of the degree of protoporphyria in the liver. (H) Histologic assessment of the degree of
inﬂammation in the livers. A four-point scale was used to assess severity where 0 represented no lesion, 1 = minimal, 2 = moderate and 3 = severe. The scores were
totaled for each group of four mice to provide an overall estimate of the severity of these changes. Bars indicate 100 µm on A and B and 20 µm on C –F.
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protoporphyrin from day 3, but C57BL/6J
mice reached maximal accumulation by
day 15 compared with the BALB/c mice,
which reached the same level of accumula-
tion by day 22. Plasma ALT and AST levels
were markedly elevated from day 3 in both
mouse stains and continued to increase sig-
nificantly relative to controls throughout
the study (Figure 2C, D); the increases were
greater in the C57BL/6J mice than in the
BALB/c strain. AP was elevated from day 5
in the C57BL/6J mice and from day 8 in
the BALB/c strain (Figure 2E). The plasma
AP levels reflected the marked strain
difference in degree of cholestasis.
Having confirmed the development of
liver injury and established a strain differ-
ence in susceptibility to griseofulvin, the
gene expression proﬁles were analyzed and
compared with the pathologic observations
and clinical chemistry. The gene expression
ratios located in the 95% conﬁdence tail for
each microarray were used for clustering
analysis (hierarchical using complete link-
age) (Figure 3). However, genes were only
considered as differentially regulated if the
p value from four independent experimental
ratios was <0.05 compared with the nor-
malized population mean using a two-tailed
t-test. The original data can be downloaded
from the MRC Toxicogenomics Unit
website.
Genes associated with pathologic change.
Pathologic change was more apparent in
C57BL/6J mice than in BALB/c mice
(Figure 1), particularly at the later time
points, and this correlated with a set of
altered gene expressions that are shown in
Figure 3A. These genes were associated by
gene expression proﬁle, and the overall gene
expression proﬁle associated with the degree
of pathologic change. Thus, the majority of
the genes in this cluster were increased in
expression from day 8 in the C57BL/6J mice
but not in the BALB/c mice. Functionally,
some of these genes are related by associa-
tion with the initiation and progression of
inflammation, and with fibrosis resulting
from the tissue repair processes.
Griseofulvin-regulated genes. Altered
expression was observed of many genes
associated directly with griseofulvin expo-
sure, and these are shown in Figure 3B, D.
The genes of these clusters were identified
as being differentially expressed as a direct
result of griseofulvin exposure rather than
subsequent pathologic change in the liver
by two further observations. First, there was
no association of expression proﬁle of these
genes with pathologic change, and second,
by comparison with the gene expression
profile of a mutant mouse model of
ferrochelatase insufficiency (Tutois et al.
1991). In these mice, differential expression
(by comparison with wild type) of the genes
shown in these clusters (Figure 3B, D) was
not observed (unpublished data).
Prominent among these are Cyp genes
including Cyp2a4 and Por (NADPH
cytochrome P450 reductase). The increased
expression of Cyp2a4 observed here may
be a cross hybridiation with Cyp2a5 known
to be increased in expression during the
development of liver injury and hepatocar-
cinomas (Camus-Randon et al. 1996;
Knasmuller et al. 1997; Salonpaa et al.
1995; Wastl et al. 1998) and is also
induced directly by porphyrinogenic agents
(Salonpaa et al. 1995). The most highly
upregulated Cyp genes in this set, Cyp2b9,
Cyp2b10, and Cyp2b13, were increased in
expression up to 100-fold. Two non-Cyp
genes reached similar levels of expression.
These were the ALAS 1 that is regulated
by heme levels and was responding to
decreased heme synthesis and Gadd45, a
DNA damage-inducible gene.
As members of the same gene super-
family, there is a possibility of cross-
reactivity between the Cyp genes on the
microarray. This was investigated by com-
paring the sequence homology. Each Cyp
gene present on the microarray used here
was compared with each of the others
(unpublished data). The only close homol-
ogy for the Cyp genes regulated in this
study is between Cyp2b10 and Cyp2b13
where there is an 83% homology based on
comparison of the full-length cDNA with
no gaps. In Figure 3B these two genes
show very similar profiles of differential
expression, and it is possible that here we
were not measuring the differential expres-
sion of both these genes but rather of
only one.
Genes increased similarly in expression
in both mice strains. Figure 3C shows genes
related by expression profile with an
increase in expression from days 5 or 8 of
the time course in both strains of mice. The
gene functions of this cluster are diverse
containing among others, Ly6d (lympho-
cyte antigen 6 complex), a lymphocytic
marker; Cstb (cathespin), an intracellular
thiol inhibitor; Nqo1 (DT-diaphorase) a
two-electron quinone oxidoreductase whose
expression is often associated with redox
stress; and another member of the annexin
family, others of which are in the cluster
shown in Figure 3A; and Krt8 (Keratin 8),
commonly associated with Mallory
body formation.
Figure 2. Data are shown as a ratio of the control value (mean control value ± SD for the experiment).
(A) Liver/body weight ratios (5.13 ± 0.43); (B) liver protoporphyrin (0.82 ± 0.39 nmol/g liver); (C) plasma ALT
(35.2 ± 32.4 U/L); (D) plasma AST (83.8 ± 73.06U/L); and (E) plasma AP (135 ± 61 U/L). The group size in each
case was four mice. Asterisk (*) indicates signiﬁcant (p < 0.05) changes from control. Signiﬁcance was
assessed using a two-tailed paired t-test.
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Figure 3. Left panel shows the full gene expression cluster analysis with increased gene expression represented by red and decreased gene expression by green,
as indicated by the key. The cluster associated with the BALB/c mice is shown on the left and that for the C57B6/AJ mice on the right with the time course, accord-
ing to the scale above. (A–F) Six individual clusters of gene associated by similarity in gene expression proﬁle and the positions of each cluster in the full cluster
proﬁle are indicated by the corresponding letter. (G–I) Sets of genes have been extracted from the main set by family (G and H) or potential relationship to inﬂam-
mation (I) before being hierarchically clustered. In all cases the genes shown as differentially expressed were signiﬁcant (p < 0.05) by comparison with the normal-
ized population mean using a two-tailed t-test and the mean and SD from four pairs of animals. This resulted in some apparent gaps in responsiveness of individual
genes at mid time points compared with adjacent data points, through the time course. This is usually caused by a high variation at these time points and loss of
signiﬁcance. In these cases, therefore, the genes are represented as nondifferentially expressed to maintain the statistical purity of the data, although the trend
indicates that the genes are in fact differentially expressed, as would be expected from the time points at either side.Genes decreased in expression. Genes
associated by a similar profile of decreased
expression in the griseofulvin-treated mice
of both strains are shown in Figure 3E, F.
Among this set, Fabp1 (fatty acid–binding
protein), also known as a heme-binding pro-
tein (Epstein et al. 1994), was decreased in
expression, a phenomenon that has been
reported previously in griseofulvin-treated
liver (Vincent et al. 1989). A downregulated
expression of three Cyp genes (Cyp4a10,
Cyp4a14, and Cyp7b1) was observed. These
are all genes represented by high abundance
mRNA, determined from the intensity of
the ﬂuorescence on the microarray (unpub-
lished data). Hsd3b4 (hydroxysteroid dehy-
drogenase-4, delta5-3-beta), a critical
enzyme in steroid hormone metabolism, was
also decreased in expression throughout the
time course (Figure 3F).
Clustering by family and function. The
clusters in Figure 3A–F were derived
through a hierarchical clustering of the
genes according to their expression proﬁle.
That is, genes that displayed similar expres-
sion proﬁles throughout the time course of
both experiments in this study were clus-
tered together regardless of the function of
the genes. This is therefore a purely mathe-
matic analysis of the data, and determina-
tion of any functional relationship between
the genes that are grouped together relies
on further analysis. An alternative approach
is to cluster the genes according to function
or name regardless of their expression pro-
ﬁle. This is a much less exacting method of
analysis mainly because the functions of
many genes are not precisely defined.
However, this method of analysis was
employed to derive the clusters shown in
Figure 3G–I. In Figure 3G all members of
the collagen gene family present on the
microarrays used have been brought
together and then hierarchically clustered.
This cluster demonstrates clearly that not
all classes of the collagen genes were
increased in expression in response to the
liver damage. There was also variation
within the classes, with two members of
the Col6a class (1 and 2) being overex-
pressed but not Col6a3. Figure 3H is a
cluster of all the family genes present on
the microarray. As with the collagen genes,
these were ﬁrst gathered together and then
hierarchically clustered. There is a clear dis-
tinction between those genes that were
decreased in expression versus those that
were increased or unchanged.
The ﬁnal cluster (Figure 3I) is a cluster
gathered not by gene family but by func-
tion. To examine the response of all genes
that might be related to inﬂammation and
therefore altered in expression in response
to the changing pathology, the Gene
Ontology terms were searched to gather a
set of genes that may be related to inﬂam-
mation. These were then hierarchically clus-
tered. The set of genes overexpressed in the
later time points of the C57BL/6J strain
shown in Figure 3A can be seen clearly in
the middle of the cluster. For the other
genes in this set, there was no alteration in
expression in either mouse type over the
time course of griseofulvin exposure.
Discussion
Our objective in this study was to explore
profiles of altered gene expression indica-
tive of ongoing pathology change in the
liver. As such, this study forms part of a
wider objective to elucidate the relevance
and application of genomics to pathologic
assessment in both a quantitative and
qualitative manner.
Two strains of mice were used in the
expectation there would be a difference in
response between the strains in a manner
similar to that found in human EP where
only a subset of individuals develop liver
damage. This was confirmed by the pres-
ence of a more intense and earlier occurring
inﬂammatory response and associated ﬁbro-
sis in the C57BL/6J strain compared with
that seen in the BALB/c, although the pre-
cise reason for these differences was not elu-
cidated. Many of the observed alterations of
gene expression were similar between strains
with the exception of one large gene cluster
(Figure 3A). The different proﬁles of altered
gene expression in the cluster could be
directly related through the time course of
griseofulvin exposure to changes in pathol-
ogy and clinical chemistry (Figures 1, 2).
Many of the genes in this cluster had a
functional association with the processes of
inflammation and fibrosis including
a) cd14, a monocyte marker and receptor
controlling the release of inflammatory
cytokines; b) Scya (small inducible cytokine
subfamily) genes that are monocyte chemo-
tactic proteins; and c) Gp49b, a leukocyte
immunoglobulin-like receptor.
Collagen deposition in and around the
biliary tracts could also be correlated with a
gene cluster that included increased expres-
sion of collagen 1a1, 3a1, 4a1, and 4a2
genes (Figure 3A, C, G). Of these, Col1a1
and Col3a1 often are both involved in
wound repair and fibrosis, and associated
with cirrhosis in the liver (Harada et al.
1999). Genes associated with wound repair
are expressed in fibroblasts in response to
serum, including the Col3a1 gene, and clus-
ters of these genes have also been identiﬁed
using microarray technology (Iyer et al.
1999). Also overexpressed, though not dif-
ferentially between the mouse strains, was
the Krt8 (Keratin 8) gene (Figure 3C).
Expression of this gene is associated with
Mallory body formation, which is known to
occur in this model (Denk et al. 1975), and
has been observed previously after 1–3 days
of feeding griseofulvin at 2.5% of the diet
(Cadrin et al. 2000). Additionally, Krt8
mutations causing keratin accumulation
predisposes to liver disease in humans, and
its presence here is probably both an indica-
tor of liver disease and a causative factor in
the progression of the fibrosis (Ku et al.
2001). Increased Ly6d gene expression that
was apparent in both mouse strains (Figure
3C) may be related to the lymphocyte inﬁl-
tration. Ly6d is used as a marker for lym-
phocytes in addition to hemopoietic stem
cells and lymphoid precursors (Classon
2001). Its presence here is then probably
related to the white cell infiltration.
However, there was less inﬂammation and
lymphocyte infiltration apparent in the
BALB/c mice compared with the C57BL/6J
strain and yet there was a similar increase in
expression of the Ly6d in both mouse
strains. Therefore, either Ly6d is an
extremely sensitive marker of lymphocyte
infiltration or there is another explanation
not apparent at the present time. Possibly
related to the onset of ﬁbrosis was increased
expression of calcyclin (S100a6) (Figure
3C) a calcium-binding protein that is asso-
ciated with metastasis and with the activa-
tion of hepatic stellate cells involved in the
development of fibrosis and cirrhosis
(Komatsu et al. 2000). The other calcium-
binding proteins in this cluster, annexin A2
(Anxa2) and annexin A6 (Anxa6), are not
reported to have such a relationship to
fibrosis, but as calcium-binding proteins,
and it is interesting to observe that they are
increased in expression in the same manner
as calcyclin.
Members of the Cyp family of genes
split into two separate clusters, some were
downregulated (Figure 3E, H) and others
were very markedly upregulated (Figure
3B, H). Those downregulated were
Cyp4a10, Cyp4a14, and Cyp7b1. Cyp7b1 is
the hydroxylase involved in taurocholate
bile acid synthesis in mice (Russell 1999).
Unlike Cyp7a1 this gene does not appear
to be downregulated by cholic acid through
the farnesoid X bile acid receptor (Sinal
et al. 2000). This suggests that regulation
of this gene may be occurring through
another mechanism sensitive to accumula-
tion of protoporphyrin. Also downregu-
lated was Hsd3b4, an enzyme essential in
steroid metabolism. Two other Cyp genes
were downregulated, Cyp4a10 and
Cyp4a14. A similar effect on the expression
of these Cyp genes is seen after treatment
with the bacterial endotoxin lipopoly-
saccharide, which also causes hepatic
Toxicogenomics | Gant et al.
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data suggest that these particular Cyp genes
may therefore be very sensitive indicators
of a liver suffering toxicity. The expression
of Cyp2a5 (coumarin-7-hydroxylase) was
induced in both C57BL/6J and BALB/c
mice (Figure 3B) and has been associated
with development of the neoplastic process
(Wastl et al. 1998). This was accompanied
by a very marked increase in expression of
Gadd45b (Figure 3B), a gene associated
with DNA damage, which has been previ-
ously associated with griseofulvin exposure
(Knasmuller et al. 1997).
Increased expression was seen of
Cyp2b10, Cyp2b13, Cyp2c29, and Cyp3a11
(Figure 3B). Previous association of griseo-
fulvin with the induction of the CypP450
genes suggests the induction of these genes
here was caused by a direct effect of the
griseofulvin rather than by the pathologic
change in the liver. This was conﬁrmed by
comparison of the data shown here with the
gene expression profile of a mouse with
homozygous mutation of the ferrrochelatase
gene (Tutois et al. 1991). In this mouse
there was no induction of the CypP450
genes shown in Figure 3B (unpublished
data). These data confirm that the induc-
tion of these CypP450 genes was a result of
a direct effect of griseofulvin and/or its
metabolites rather than a consequence of
pathologic change. The opposite was true,
however, for the downregulated CypP450
genes in Figure 3E that were also downreg-
ulated in the homozygous ferrrochelatase
mutant mouse.
To conclude, we have shown that gene
expression proﬁles could be directly related
to the evolution of the inflammatory
process and subsequent hepatic fibrosis, as
well as profiles related to the compound
itself and adaptive changes in cellular bio-
chemistry. We have shown the utility and
potential ability of gene expression proﬁles
to delineate and predict pathologic change.
However, more information is required to
model the networks of gene regulation that
determine the occurrence and extent of
hepatic ﬁbrosis in response to liver damage
and inﬂammation.
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